News
Chevron Invests in Geothermal Development Company
Chevron Corporation (NYSE: CVX) today announced an investment in Baseload Capital AB, a Sweden-based private investment company focused on development and operation of low-temperature geothermal
Chevron Announces First Gas From the Alen Gas Monetization Project in Equatorial Guinea
Noble Energy EG Ltd. (a Chevron Company) has achieved first gas flow from the safe and successful execution of the Alen Gas Monetization Project. The project consists of a 70 km (43.5 miles)
European Medicines Agency Accepts Pfizer’s Marketing Authorization Application for Its Investigational 20-valent Pneumococcal Conjugate Vaccine for Adults 18 Years of Age or Older
Pfizer Inc. (NYSE:PFE) today announced that the European Medicines Agency (EMA) accepted for review the Marketing Authorization Application (MAA) for its 20-valent pneumococcal conjugate vaccine
EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency
Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the European Medicines Agency (EMA) has validated for review the Marketing Authorization Application (MAA) for
Chevron Commits $300 million Toward Low-Carbon Technology Investments
Chevron Technology Ventures, LLC (CTV) today announced the launch of its $300 million Future Energy Fund II focused on technologies that have the potential to enable affordable, reliable, and
Walmart to Present at Both the Raymond James Institutional Investors Conference and the UBS Global Consumer and Retail Virtual Conference
Walmart Inc. (NYSE: WMT) announced today that Brett Biggs, executive vice president and chief financial officer, will participate at the virtual Raymond James 42nd Annual Institutional Investors
Pfizer and BioNTech Initiate a Study as Part of Broad Development Plan to Evaluate COVID-19 Booster and New Vaccine Variants
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today they have begun an evaluation of the safety and immunogenicity of a third dose of the Pfizer-BioNTech COVID-19 vaccine
Microsoft Corporation, Fundamental Analysis for long term investing approach.
U.S. FDA Accepts for Priority Review Pfizer’s Application for TicoVac™ (Tick-borne Encephalitis Vaccine)
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for Priority Review the company’s Biologics License Application (BLA) for TicoVac™, its tick-borne
American Express and the National Trust for Historic Preservation Announce $1+ Million Grant Program for “Backing Historic Small Restaurants” in the U.S.
American Express (NYSE: AXP), in partnership with the National Trust for Historic Preservation, today announced “Backing Historic Small Restaurants,” a more than $1 million investment to preserve
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Angela Hwang, Group President, Pfizer Biopharmaceuticals Group, at the Cowen 41st Annual
American Express and Hilton CEOs to Participate in Joint Conversation at Citi Virtual Global Property CEO Conference
American Express Co. (NYSE: AXP) Chairman and Chief Executive Officer Stephen J. Squeri will participate in a joint question-and-answer session with Hilton Worldwide Holdings Inc. (NYSE: HLT)
NIKE, Inc. Announces Third Quarter Fiscal 2021 Earnings and Conference Call
NIKE, Inc. (NYSE: NKE) plans to release its third quarter fiscal 2021 financial results on Thursday, March 18, 2021, at approximately 1:15 p.m. PT, following the close of regular stock market
Walmart reports record Q4 and FY21 revenue
Walmart Inc. (NYSE: WMT):
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210218005552/en/
Fourth-quarter highlights
-
Walmart U.S
Walmart raises annual dividend to $2.20 per share, marking 48th consecutive year of dividend increases
The Board of Directors of Walmart Inc. (NYSE: WMT) approved an annual cash dividend for fiscal year 2022 of $2.20 per share, an increase of approximately 2 percent from the $2.16 per share paid for
American Express to Open New Centurion® Lounge at Ronald Reagan Washington National Airport and Expand Centurion Lounges in Seattle and San Francisco
American Express (NYSE: AXP) today announced plans to open its 16th Centurion Lounge at Washington, D.C.’s, Reagan National Airport (DCA), and expand its Seattle-Tacoma International Airport (SEA)
Pfizer Initiates Pivotal Phase 2 MagnetisMM-3 Trial of BCMA-CD3 Bispecific Antibody Elranatamab (PF-06863135) in Multiple Myeloma
Pfizer Inc. (NYSE:PFE) today announced that the first participant has been dosed in the registration-enabling Phase 2 MagnetisMM-3 study (NCT04649359) of elranatamab (PF-06863135), an
Pfizer and BioNTech to Supply the European Union with 200 Million Additional Doses of COMIRNATY®
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced an agreement with the European Commission (EC) to supply an additional 200 million doses of COMIRNATY®, the companies’
U.S. FDA Approves PANZYGA® for the Treatment of Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for PANZYGA® (Immune Globulin Intravenous
NIKE, Inc. Declares $0.275 Quarterly Dividend
NIKE, Inc. (NYSE: NKE) announced today that its Board of Directors has declared a quarterly cash dividend of $0.275 per share on the company’s outstanding Class A and Class B Common Stock payable
American Express Chief Financial Officer to Participate in KBW Fintech Payments Conference
American Express (NYSE: AXP) Chief Financial Officer Jeffrey C. Campbell will participate in the Keefe, Bruyette & Woods (KBW) Fintech Payments Conference on Tuesday, February 23 at 8:50 a.m. (ET)
Pfizer Confirms U.S. Patent Term Extension for IBRANCE® (palbociclib) Until March 2027
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Patent and Trademark Office (USPTO) recently issued a U.S. Patent Term Extension (PTE) certificate for IBRANCE® (palbociclib). The certificate
Chevron Announces Offer to Acquire Noble Midstream Partners LP
Chevron Corporation (NYSE: CVX) announced today that it has submitted a non-binding proposal to the Board of Directors of Noble Midstream GP LLC, the general partner of Noble Midstream Partners LP
The American Express® Gold Card Brings Back the Iconic Rose Gold Design & Launches a New Uber Cash Benefit
Today, American Express (NYSE: AXP) announced that its popular metal Rose Gold Card design is coming back as a color option for the U.S. Consumer American Express Gold Card. The news comes in
PFIZER REPORTS FOURTH-QUARTER AND FULL-YEAR 2020 RESULTS AND RELEASES 5-YEAR PIPELINE METRICS
Pfizer Inc. (NYSE: PFE) reported financial results for fourth-quarter 2020 and full-year 2020, raised 2021 guidance(4) for Adjusted diluted EPS(2) and provided 2021 financial guidance(4) for other